Innoviva – World Class Benchmarking
Company: Innoviva Incorporated
Bloomberg ticker: INVA US
Market cap: US$1,609m
Background: Innoviva Incorporated is a diversified healthcare asset management company headquartered in the United States that operates globally. The business manages a lucrative pharmaceutical royalty portfolio and sells specialty therapeutics. It is known for critical care products like Giapreza, Xerava, and Breo Ellipta.
World Class Benchmarking of Innoviva
- Profitable Growth rank of 1 was up compared to the prior period’s 8th rank
- This is World Class performance compared to 310 medium Health Care companies worldwide
- Profitability rank of 1 was the same as its Growth rank of 1
- Profitability rank of 1 was up compared to the prior period’s 7th rank
- This is World Class performance compared to peers
- Growth rank of 1 was up compared to the prior period’s 10th rank
- This is World Class performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.